METTL3 and acute myeloid leukemia: By targeting the METTL3 subunit, compound 15 selectively binds to the METTL3/14 complex and interacts with an allosteric site on the complex, affecting enzyme activity and thereby reducing m6A levels in cells, ultimately exhibiting activity against AML.